Bacteriophage lysins as effective antibacterials

Current Opinion in Microbiology

Volumn 11, Issue 5, 2008, Pages 393-400

  Fischetti, Vincent A ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDASE; ANTIINFECTIVE AGENT; CPL 1; GAMMA LYSIN; GENTAMICIN; HYDROLASE; LYSIN; LYSOZYME; PENICILLIN G; UNCLASSIFIED DRUG;

ANTHRAX; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL CELL; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIOLYSIS; BACTERIOPHAGE; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG STRUCTURE; ENDOCARDITIS; ENZYME STRUCTURE; GRAM POSITIVE BACTERIUM; HUMAN; INFLUENZA; MENINGITIS; MUCOSA; NONHUMAN; OTITIS MEDIA; PNEUMONIA; REVIEW; SECONDARY INFECTION; SEPSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BACTERIOLYSIS; BACTERIOPHAGES; DRUG RESISTANCE, MICROBIAL; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL VIABILITY; VIRAL PROTEINS;

ANIMALIA; BACTERIA (MICROORGANISMS); POSIBACTERIA;

EID: 55049135817     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mib.2008.09.012     Document Type: Review

References (55)

1. Loessner M.J., Maier S.K., Daubek-Puza H., Wendlinger G., and Scherer S. Three Bacillus cereus bacteriophage endolysins are unrelated but reveal high homology to cell wall hydrolases from different bacilli. J Bacteriol 179 (1997) 2845-2851
2. Wang I.-N., Smith D.L., and Young R. Holins: the protein clocks of bacteriophage infections. Annu Rev Microbiol 54 (2000) 799-825
3. Wang I.-N., Deaton J., and Young R. Sizing the Holin Lesion with an Endolysin-beta-Galactosidase fusion. J Bacteriol 185 (2003) 779-787
4. Young R., Wang I.-N., and Roof W.D. Phages will out: strategies of host cell lysis. Trends Microbiol 8 (2000) 120-128
5. Bernhardt T.G., Wang I.N., Struck D.K., and Young R. A protein antibiotic in the phage Q-beta virion: diversity in lysis targets. Science 292 (2001) 2326-2329
6. Matsuzaki S., Rashel M., Uchiyama J., Sakurai S., Ujihara T., Kuroda M., Ikeuchi M., Tani T., Fujieda M., Wakiguchi H., and Imai S. Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. J Infect Chemother 11 (2005) 211-219
7. Nelson D., Loomis L., and Fischetti V.A. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci U S A 98 (2001) 4107-4112. This is the first publication showing that phage lysins may be used in vivo for bacterial decolonization of mucous membranes.
8. Loeffler J.M., Djurkovic S., and Fischetti V.A. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect Immun 71 (2003) 6199-6204. This paper shows that lysins function in blood to kill bacteria.
9. Schuch R., Nelson D., and Fischetti V.A. A bacteriolytic agent that detects and kills Bacillus anthracis. Science 418 (2002) 884-889
10. Eiff C.V., Becker K., Machka K., Stammer H., and Peters G. Nasal carriage as a source of Staphlococcus aureus bacteremia. N Engl J Med 344 (2001) 11-16. This paper shows that the staphylococci you carry are the ones that cause infection.
11. Coello R., Jimenez J., Garcia M., Arroyo P., Minguez D., Fernandez C., Cruzet F., and Gaspar C. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis 13 (1994) 74-81
12. de Lencastre H., Kristinsson K.G., Brito-Avo A., Sanches I.S., Sa-Leao R., Saldanha J., Sigvaldadottir E., Karlsson S., Oliveira D., Mato R., et al. Carriage of respiratory tract pathogens and molecular epidemiology of Streptococcus pneumoniae colonization in healthy children attending day acre centers in lisbon, portugal. Microb Drug Resist 5 (1999) 19-29
13. Hudson I. The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience. J Hosp Infect 28 (1994) 235
14. Young R. Bacteriophage lysis: mechanism and regulation. Microbiol Rev 56 (1992) 430-481
15. Loeffler J.M., Nelson D., and Fischetti V.A. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294 (2001) 2170-2172
16. Nelson D., Schuch R., Chahales P., Zhu S., and Fischetti V.A. PlyC: a multimeric bacteriophage lysin. Proc Natl Acad Sci U S A 103 (2006) 10765-10770
17. Diaz E., Lopez R., and Garcia J.L. Chimeric phage-bacterial enzymes: a clue to the modular evolution of genes. Proc Natl Acad Sci U S A 87 (1990) 8125-8129
18. Garcia P., Garcia J.L., Garcia E., Sanchez-Puelles J.M., and Lopez R. Modular organization of the lytic enzymes of Streptococcus pneumoniae and its bacteriophages. Gene 86 (1990) 81-88. One of the earliest studies showing that phage lysins have a modular organisation.
19. Loessner M.J. Bacteriophage endolysins-current state of research and applications. Curr Opi Microbiol 8 (2005) 480-487
20. Pritchard D.G., Dong S., Kirk M.C., Cartee R.T., and Baker J.R. LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae. Appl Environ Microbiol 73 (2007) 7150-7154
21. Navarre W.W., Ton-That H., Faull K.F., and Schneewind O. Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a d-alanyl-glycine endopeptidase activity. J Biol Chem 274 (1999) 15847-15856
22. Lopez R., Garcia E., Garcia P., and Garcia J.L. The pneumococcal cell wall degrading enzymes: a modular design to create new lysins?. Microb Drug Resist 3 (1997) 199-211
23. ••] show that the lysin domains may be swapped to make new enzymes.
24. Garcia E., Garcia J.L., Arraras A., Sanchez-Puelles J.M., and Lopez R. Molecular evolution of lytic enzymes of Streptococcus pneumoniae and its bacteriophages. Proc Natl Acad Sci U S A 85 (1988) 914-918
25. Hermoso J.A., Monterroso B., Albert A., Galan B., Ahrazem O., Garcia P., Martinez-Ripoli M., Garcia J.L., and Menendez M. Structural basis for selective recognition of pneumococcal cell wall by modular endolysin from phage Cp-1. Structure 11 (2003) 1239-1249. This is the first complete structure of a lysine.
26. Loessner M.J., Kramer K., Ebel F., and Scherer S. C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates. Mol Microbiol 44 (2002) 335-349. This is the first paper to show that lysins bind to their cell wall substrates at high affinity.
27. Weiss K., Laverdiere M., Lovgren M., Delorme J., Poirier L., and Beliveau C. Group A Streptococcus carriage among close contacts of patients with invasive infections. Am J Epidemiol 149 (1999) 863-868
28. Foley S., Bruttin A., and Brussow H. Widespread distribution of a group I intron and its three deletion derivatives in the lysin gene of Streptococcus thermophilus bacteriophages. J Virol 74 (2000) 611-618
29. Flaherty S.O., Coffey A., Meaney W., Fitzgerald G.F., and Ross R.P. Genome of staphylococcal phage K: a new lineage of Myoviridae infecting Gram- positive bacteria with a low G + C content. J Bacteriol 186 9 (2004) 2862-2871 Ref Type: Generic
30. Nelson D., Schuch R., Zhu S., Tscherne D.M., and Fischetti V.A. Genomic sequence of C1, the first streptococcal phage. J Bacteriol 185 11 (2003) 3325-3332
31. Fernandez-Lopez M., Munoz-Adelantado E., Gillis M., Williams A., and Toro N. Dispersal and evolution of the Sinorhizobium meliloti group II RmInt1 Intron in bacteria that interact with plants. Mol Biol Evol 22 (2005) 1518-1528
32. Tan K., Ong G., and Song K. Introns in the cytolethal distending toxin gene of Actinobacillus Actinomycetemcomitans. J Bacteriol 187 (2005) 567-575
33. Jervis E.J., Haynes C.A., and Kilburn D.G. Surface diffusion of cellulases and their isolated binding domains on cellulose. J Biol Chem 272 (1997) 24016-24023
34. Yoong P., Schuch R., Nelson D., and Fischetti V.A. Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium. J Bacteriol 186 (2004) 4808-4812
35. Rashel M., Uchiyama J., Ujihara T., Uehara Y., Kuramoto S., Sugihara S., Yagyu K., Muraoka A., Sugai M., Hiramatsu K., et al. Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. J Infect Dis 196 (2007) 1237-1247
36. Sass P., and Bierbaum G. Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus. Appl Environ Microbiol 73 (2007) 347-352
37. O'Flaherty S., Coffey A., Meaney W., Fitzgerald G.F., and Ross R.P. The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. J Bacteriol 187 (2005) 7161-7164
38. Clyne M., Birkbeck T.H., and Arbuthnott J.P. Characterization of staphylococcal Y-lysin. J Gen Microbiol 138 (1992) 923-930
39. Sonstein S.A., Hammel J.M., and Bondi A. Staphylococcal bacteriophage-associated lysin: a lytic agent active against Staphylococcus aureus. J Bacteriol 107 (1971) 499-504
40. Loeffler J.M., and Fischetti V.A. Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains. Antimicrob Agents Chemother 47 (2003) 375-377. First paper to show synergy between lysins and along with reference [43], synergy with antibiotics.
41. Eliopoulos G., and Moellering R. Antimicrobial combinations. In: Lorian V. (Ed). Antibiotics in Laboratory Medicine (1991), Williams and Wilkins, Baltimore
42. Jado I., Lopez R., Garcia E., Fenoll A., Casal J., and Garcia P. Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. J Antimicrob Chemother 52 (2003) 967-973
43. Djurkovic S., Loeffler J.M., and Fischetti V.A. Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance. Antimicrob Agents Chemother 49 (2005) 1225-1228
44. Cheng Q., Nelson D., Zhu S., and Fischetti V.A. Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob Agents Chemother 49 (2005) 111-117
45. Walsh S., Shah A., and Mond J. Improved Pharmacokinetics and reduced antibody reactivity of lysostaphin conjugated to polyethylene glycol. Antimicrob Agents Chemother 47 (2003) 554-558
46. Grandgirard D., Loeffler J.M., Fischetti V.A., and Leib S.L. Phage lytic enzyme cpl-1 for antibacterial therapy in experimental pneumococcal meningitis. J Infect Dis 197 (2008) 1519-1522
47. Entenza J.M., Loeffler J.M., Grandgirard D., Fischetti V.A., and Moreillon P. Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats. Antimicrob Agents Chemother 49 (2005) 4789-4792
48. Kengatharan K.M., De K.S., Robson C., Foster S.J., and Thiemermann C. Mechanism of Gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. J Exp Med 188 (1998) 305-315
49. Tuomanen E., Liu H., Hengstler B., Zak O., and Tomasz A. The induction of meningeal inflammation by components of the pneumococcal cell wall. J Infect Dis 151 (1985) 859-868
50. Watanabe T., Morimoto A., and Shiomi T. The fine structure and the protein composition of gamma phage of Bacillus anthracis. Can J Microbiol 21 (1975) 1889-1892
51. Garcia P., Garcia E., Ronda C., Tomasz A., and Lopez R. Inhibition of lysis by antibody against phage-associated lysin and requirement of choline residues in the cell wall for progeny phage release in Streptococcus pneumoniae. Curr Microbiol 8 (1983) 137-140
52. Brundage J.F., and Shanks G.D. What really happened during the 1918 influenza pandemic? The importance of bacterial secondary infections. J Infect Dis 196 (2007) 1717-1718
53. Brundage J.F., and Shanks G.D. Deaths from bacterial pneumonia during 1918-19 influenza pandemic. Emerg Infect Dis 14 (2008) 1193-1199
54. McCullers J.A. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 19 (2006) 571-582
55. McCullers J.A., et al. Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae. PLoS Pathog 3 (2007) e28